ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
노로바이러스 치료 시장 규모는 최근 급성장하고 있습니다. 2025년 19억 4,000만 달러에서 2026년에는 21억 5,000만 달러에 이르고, CAGR 10.9%의 성장이 전망되고 있습니다. 지금까지의 성장은 노로바이러스 관리에 대한 인식 부족, 병원 기반 치료에 대한 의존도, 재택의료 인프라 미비, 표준화된 증상 관리 프로토콜 부족, 프로바이오틱스 및 아연 보충제 도입률 저조 등이 원인으로 추정됩니다.
노로바이러스 치료 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 32억 2,000만 달러에 이르고, CAGR은 10.6%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 경구용 수액에 대한 수요 증가, 재택치료 서비스 및 원격 의료의 확대, 소아 및 노인층에 대한 관심 증가, 표적화된 지지 요법 개발, 의료비 지출 증가, 인식 개선 캠페인 전개 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 경구용 수액 요법의 채택 증가, 중증 환자에서 정맥 수액 사용 증가, 재택치료 및 원격 치료 옵션의 성장, 항설사제 및 증상 관리 약물의 사용 확대, 소아 및 노인을 위한 노로바이러스 케어에 대한 관심 증가 등이 있습니다.
감염성 질환의 유병률 증가는 향후 몇 년 동안 노로바이러스 치료제 시장의 성장을 가속할 것으로 예측됩니다. 감염병이란 세균, 바이러스, 진균, 곰팡이, 기생충에 의해 발생하여 사람에게 감염되는 질병으로 독감, 결핵, HIV/에이즈, 말라리아, 노로바이러스 등이 포함됩니다. 도시 과밀화로 인해 인구 밀집 지역에서의 병원체 전파가 가속화되어 감염병 발생률이 증가하고 있습니다. 노로바이러스 치료는 적절한 수분 보충, 위생 관리, 격리 조치를 통해 증상을 효과적으로 관리하고 감염 전파를 억제함으로써 감염증의 영향을 줄이는 데 도움이 됩니다. 예를 들어, 스위스에 본부를 둔 정부 간 기구인 세계보건기구(WHO)에 따르면, 2023년에는 전 세계적으로 약 1,080만 명이 결핵에 감염될 것이며, 그 중 남성 600만 명, 여성 360만 명, 어린이 130만 명이 결핵에 감염될 것으로 예상했습니다. 따라서 감염성 질환의 확산이 노로바이러스 치료제 시장의 성장을 가속하고 있습니다.
노로바이러스 치료제 시장에서 활동하는 주요 기업들은 첨단 mRNA 백신과 같은 혁신적인 접근법 개발에 주력하고 있습니다. 이를 통해 표적 면역의 신속화, 중증 감염에 대한 방어력 강화, 노로바이러스 관련 질병에 대한 전 세계 부담 경감을 목표로 하고 있습니다. 첨단 mRNA 백신은 차세대 면역기술로, 설계된 메신저 RNA를 이용하여 세포에 특정 단백질을 생산하도록 하여 다양한 감염질환에 대해 안정성, 유효성, 적응성을 높인 표적 면역반응을 유도하는 차세대 면역기술입니다. 예를 들어, 2024년 10월, 미국 소재 생명공학 기업 Moderna Inc.는 영국 정부 기관인 영국보건안전청(UKHSA)과 협력하여 mRNA 노로바이러스 백신(mRNA-1403)의 세계 최초 임상 3상 시험을 영국에서 시작하였습니다. 시작하였습니다. 이번 시험에서는 생바이러스를 사용하지 않고 강력한 면역반응을 자극하는 바이러스 단백질을 체내에서 생성시켜 감염력이 강한 노로바이러스에 대항하는 백신을 도입합니다. 안정화 mRNA를 통한 내구성 향상, 돌연변이주에 대응할 수 있는 신속한 개발 능력, 항체 반응과 T세포 반응을 모두 유도할 수 있는 능력 등이 주요 특징입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Norovirus treatment focuses on supportive care to ease symptoms such as vomiting, diarrhea, and abdominal pain caused by the infection. It mainly includes maintaining proper hydration, ensuring adequate rest, and managing symptoms, as there is currently no specific antiviral therapy available for norovirus.
The primary treatment options for norovirus include electrolytes, intravenous fluids, antipyretics, analgesics, anti-diarrheal medications, and others. Electrolytes are essential minerals that carry an electric charge and support critical body functions such as nerve transmission, muscle activity, fluid balance, and pH regulation. Diagnostic approaches include stool testing, bacterial culture tests, and other methods. These treatments are administered through oral, intravenous, or subcutaneous routes and are used by end users such as hospitals, clinics, and homecare settings.
Tariffs have affected the norovirus treatment market by increasing the cost of imported intravenous fluids, electrolytes, and pharmaceutical-grade antipyretics. Segments like crystalloids, lactated ringer's solution, and pediatric electrolyte solutions are particularly impacted, with regions such as North America and Asia-Pacific facing supply chain disruptions. While tariffs raise treatment costs, they also encourage local manufacturing of supportive care products and development of cost-effective alternatives, strengthening domestic healthcare resilience.
The norovirus treatment market research report is one of a series of new reports from The Business Research Company that provides norovirus treatment market statistics, including norovirus treatment industry global market size, regional shares, competitors with a norovirus treatment market share, detailed norovirus treatment market segments, market trends and opportunities, and any further data you may need to thrive in the norovirus treatment industry. This norovirus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The norovirus treatment market size has grown rapidly in recent years. It will grow from $1.94 billion in 2025 to $2.15 billion in 2026 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to limited awareness of norovirus management, reliance on hospital-based treatments, insufficient homecare infrastructure, lack of standardized symptom management protocols, low adoption of probiotics and zinc supplementation.
The norovirus treatment market size is expected to see rapid growth in the next few years. It will grow to $3.22 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to growing demand for oral rehydration solutions, expansion of homecare services and telemedicine, increasing pediatric and elderly population focus, development of targeted supportive care therapies, rising healthcare expenditure and awareness campaigns. Major trends in the forecast period include increasing adoption of oral rehydration therapies, rising use of intravenous fluids in severe cases, growth in homecare and remote treatment options, expanded use of anti-diarrheal and symptom management drugs, focus on pediatric and geriatric norovirus care.
The rising prevalence of infectious diseases is anticipated to drive the growth of the norovirus treatment market in the coming years. Infectious diseases are conditions caused by bacteria, viruses, fungi, or parasites that spread among people and include illnesses such as influenza, tuberculosis, HIV/AIDS, malaria, and norovirus. The incidence of infectious diseases is increasing due to urban overcrowding, which enables more rapid transmission of pathogens within densely populated areas. Norovirus treatment helps mitigate the impact of infectious diseases by effectively managing symptoms and reducing transmission through appropriate hydration, hygiene, and isolation measures. For instance, in March 2025, according to the World Health Organization, a Switzerland-based intergovernmental organization, approximately 10.8 million people worldwide contracted tuberculosis in 2023, including 6.0 million men, 3.6 million women, and 1.3 million children. Therefore, the increasing prevalence of infectious diseases is fueling the growth of the norovirus treatment market.
Major companies operating in the norovirus treatment market are concentrating on the development of innovative approaches, such as advanced mRNA vaccines, to speed up targeted immunization, strengthen protection against severe infections, and lower the global burden of norovirus-related diseases. Advanced mRNA vaccines are next-generation immunization technologies that utilize engineered messenger RNA to direct cells to produce specific proteins, thereby triggering a targeted immune response with enhanced stability, effectiveness, and adaptability against a range of infectious diseases. For example, in October 2024, Moderna Inc., a US-based biotechnology company, partnered with the UK Health Security Agency (UKHSA), a UK-based government organization, to launch the world's first Phase 3 clinical trial of an mRNA norovirus vaccine (mRNA-1403) in the UK. This trial introduces a vaccine designed to combat highly contagious norovirus by prompting the body to generate viral proteins that stimulate a robust immune response without the use of live virus. Key features of this initiative include the use of stabilized mRNA for improved durability, rapid development capabilities to address evolving strains, and the ability to induce both antibody and T-cell immune responses.
In March 2024, Kenvue Inc., a US-based consumer healthcare company, entered into a partnership with the Association of Physicians of India (API) to advance public health awareness and preventive care programs. Through this collaboration, Kenvue seeks to improve clinical guidance on hydration and energy management for hospitalized patients with non-diarrheal conditions by supporting evidence-based recommendations developed jointly with the Association of Physicians of India. The Association of Physicians of India (API) is an India-based professional organization representing physicians specializing in internal medicine.
Major companies operating in the norovirus treatment market are Abbott Laboratories, Reckitt Benckiser Group plc, Nestle Health Science, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG, Hikma Pharmaceuticals PLC, Torrent Pharmaceuticals Ltd., Alkem Laboratories Ltd., Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Ltd., Pfizer Healthcare India Pvt. Ltd., Mead Johnson Nutrition (Reckitt), Danone Nutricia, Amneal Pharmaceuticals Inc., Ajanta Pharma Ltd.
North America was the largest region in the norovirus treatment market in 2025. The regions covered in the norovirus treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the norovirus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The norovirus treatment market includes revenues earned by entities by providing services such as symptom management, rehydration therapy, and stool tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The norovirus treatment market also includes sales of oral rehydration solutions (ORS), anti-nausea medications, thermometers, disinfectants, and cleaning products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Norovirus Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses norovirus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for norovirus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The norovirus treatment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Treatment: Electrolytes; Intravenous Fluids; Antipyretics; Analgesics; Anti-Diarrheal; Other Treatments
2) By Diagnosis: Bacteria Culture Test; Stool Tests; Other Diagnosis
3) By Route Of Administration: Oral; Intravenous
4) By End User: Hospitals; Clinics; Homecare Settings
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Oral Rehydration Therapies
4.2.2 Rising Use Of Intravenous Fluids In Severe Cases
4.2.3 Growth In Homecare And Remote Treatment Options
4.2.4 Expanded Use Of Anti-Diarrheal And Symptom Management Drugs
4.2.5 Focus On Pediatric And Geriatric Norovirus Care
5. Norovirus Treatment Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Homecare Settings
5.4 Pediatric Care Centers
5.5 Geriatric Care Facilities
6. Norovirus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Norovirus Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Norovirus Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Norovirus Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Norovirus Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Norovirus Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Norovirus Treatment Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Norovirus Treatment Market Segmentation
9.1. Global Norovirus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Electrolytes, Intravenous Fluids, Antipyretics, Analgesics, Anti-Diarrheal, Other Treatments
9.2. Global Norovirus Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Bacteria Culture Test, Stool Tests, Other Diagnosis
9.3. Global Norovirus Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Intravenous
9.4. Global Norovirus Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Homecare Settings, Pediatric Care Centers
9.5. Global Norovirus Treatment Market, Sub-Segmentation Of Electrolytes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.6. Global Norovirus Treatment Market, Sub-Segmentation Of Intravenous Fluids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Norovirus Treatment Market
12.1. China Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Norovirus Treatment Market
13.1. India Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Norovirus Treatment Market
14.1. Japan Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Norovirus Treatment Market
15.1. Australia Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Norovirus Treatment Market
16.1. Indonesia Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Norovirus Treatment Market
17.1. South Korea Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Norovirus Treatment Market
18.1. Taiwan Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Norovirus Treatment Market
19.1. South East Asia Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Norovirus Treatment Market
20.1. Western Europe Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Norovirus Treatment Market
21.1. UK Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Norovirus Treatment Market
22.1. Germany Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Norovirus Treatment Market
23.1. France Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Norovirus Treatment Market
24.1. Italy Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Norovirus Treatment Market
25.1. Spain Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Norovirus Treatment Market
26.1. Eastern Europe Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Norovirus Treatment Market
27.1. Russia Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Norovirus Treatment Market
28.1. North America Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Norovirus Treatment Market
29.1. USA Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Norovirus Treatment Market
30.1. Canada Norovirus Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Norovirus Treatment Market
31.1. South America Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Norovirus Treatment Market
32.1. Brazil Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Norovirus Treatment Market
33.1. Middle East Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Norovirus Treatment Market
34.1. Africa Norovirus Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Norovirus Treatment Market, Segmentation By Treatment, Segmentation By Diagnosis, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Norovirus Treatment Market Regulatory and Investment Landscape
36. Norovirus Treatment Market Competitive Landscape And Company Profiles
36.1. Norovirus Treatment Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Norovirus Treatment Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Norovirus Treatment Market Company Profiles
36.3.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
37. Norovirus Treatment Market Other Major And Innovative Companies
Cipla Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Lupin Limited, Mylan (Viatris Inc.), Perrigo Company plc, Haleon plc, Church & Dwight Co. Inc., GlaxoSmithKline Consumer Healthcare, Sanofi Consumer Healthcare, Pfizer Consumer Healthcare, Ferring Pharmaceuticals, Fresenius Kabi AG, Baxter International Inc., B. Braun Melsungen AG
38. Global Norovirus Treatment Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Norovirus Treatment Market
40. Norovirus Treatment Market High Potential Countries, Segments and Strategies
40.1 Norovirus Treatment Market In 2030 - Countries Offering Most New Opportunities
40.2 Norovirus Treatment Market In 2030 - Segments Offering Most New Opportunities
40.3 Norovirus Treatment Market In 2030 - Growth Strategies
